Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymund R Razonable

Showing results (1-10 of 300) with videos related to

Pageof 30
Sort By:
Current Opinion in Organ Transplantation|May 26, 2018
Drug-resistant cytomegalovirus: clinical implications of specific mutationsRaymund R Razonable
Current Opinion in Organ Transplantation|October 18, 2011
Rare, unusual, and less common virus infections after organ transplantationRaymund R Razonable
Seminars in Nephrology|October 25, 2016
Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney TransplantationRaymund R Razonable
Hepatology (Baltimore, Md.)|September 3, 2010
Innate immune genetic profile to predict infection risk and outcome after liver transplantRaymund R Razonable
Expert Opinion on Pharmacotherapy|July 21, 2010
Strategies for managing cytomegalovirus in transplant recipientsRaymund R Razonable
Frontiers in Immunology|August 9, 2024
Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunityRaymund R Razonable
Immunotherapy|July 20, 2010
Immune-based therapies for cytomegalovirus infectionRaymund R Razonable
Current Pharmaceutical Design|June 1, 2020
Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future DirectionsRaymund R Razonable
Frontiers in Immunology|May 17, 2024
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunityRaymund R Razonable
Current Opinion in Organ Transplantation|October 1, 2010
Infections due to human herpesvirus 6 in solid organ transplant recipientsRaymund R Razonable
Pageof 30

Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
Current Opinion in Organ Transplantation|May 26, 2018
Drug-resistant cytomegalovirus: clinical implications of specific mutationsRaymund R Razonable
Current Opinion in Organ Transplantation|October 18, 2011
Rare, unusual, and less common virus infections after organ transplantationRaymund R Razonable
Seminars in Nephrology|October 25, 2016
Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney TransplantationRaymund R Razonable
Hepatology (Baltimore, Md.)|September 3, 2010
Innate immune genetic profile to predict infection risk and outcome after liver transplantRaymund R Razonable
Expert Opinion on Pharmacotherapy|July 21, 2010
Strategies for managing cytomegalovirus in transplant recipientsRaymund R Razonable
Frontiers in Immunology|August 9, 2024
Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunityRaymund R Razonable
Immunotherapy|July 20, 2010
Immune-based therapies for cytomegalovirus infectionRaymund R Razonable
Current Pharmaceutical Design|June 1, 2020
Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future DirectionsRaymund R Razonable
Frontiers in Immunology|May 17, 2024
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunityRaymund R Razonable
Current Opinion in Organ Transplantation|October 1, 2010
Infections due to human herpesvirus 6 in solid organ transplant recipientsRaymund R Razonable
Pageof 30